Globe Roche Logo
Roche Disease Areas

Disease Areas

Roche Molecular Diagnostics offers a uniquely broad menu of kits and assays for diagnosing and monitoring various diseases.

Learn more about disease-specific diagnostic solutions offerings from Roche Molecular, and get additional information on the assays and systems you rely on for accurate, robust results.

Sexual Health

Sexual Health

More than a million sexually transmitted infections (STIs) are acquired each day. Roche Molecular Diagnostics understands the need for reliable and available diagnostic testing, especially in resource-limited settings, and is committed to making sure people around the world have access to accurate diagnoses to inform proper treatment decisions.

Hospital-Acquired Infections

Hospital-Acquired Infections

Hospital-acquired infections may prolong institutional stays, create long-term disability, and place a tremendous financial burden on health systems. Roche Molecular Diagnostics offers both diagnostic and research-oriented assays to accurately and reliably detect these potentially deadly infections.

Oncology

Oncology

We know more about what can be done to prevent cancer than ever before. With a range of oncological assays designed to identify gene mutations, Roche Molecular Diagnostic products provide clarity on complicated treatment decisions, to inspire better patient care.

Other Diseases

Other Diseases

Roche Molecular Diagnostics is committed to delivering quality diagnostic products to support treatment decisions. Explore our expanding menu of available products and thank you for putting your trust in Roche.

Seasonal

Seasonal

Seasonal infections of humans, including childhood diseases, respiratory infections and vector-borne disease, show characteristic surges in their infection rates during certain times of the year, increasing the burden on healthcare systems and creating an increased need for accurate and reliable diagnostic testing. Roche Molecular Diagnostics offers molecular system solutions which bring effective seasonal infection management from rapid, single sample identification at the point-of-care setting, to high-throughput screening needs of the mid- and high-volume laboratories.

Transplant

Transplant

Cytomegalovirus (CMV) is a common virus found in people of all ages—more than half of all adults have been infected by the age of 40. Cytomegalovirus (CMV) is a leading cause of morbidity and mortality in transplant recipients. Severe CMV infection in high risk patients may occur soon after transplantation. Roche is committed to helping deter the spread and reactivation of the Cytomegalovirus and provides WHO-standardized assays to detect and monitor the progression of CMV infections.

Virology

Virology

Virology has two decades of leadership and expertise in pioneering technological "firsts", such as the dual target and dual probe approaches developed for the latest generation of HIV-1 and HCV viral load assays. Roche viral load HIV-1, HCV, HBV, and CMV assays are the most trusted for clinical trials and have been at the forefront of pharmaceutical and clinical research. With over 100 million viral load tests performed worldwide Roche assays are the most clinically validated.

Contact us

Have a question? Get in touch with us here and we’ll work to get you the answers you need from one of our experts.

Contact